Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K2DR
|
||||
Former ID |
DNC009638
|
||||
Drug Name |
5-Pyridin-3-yl-1,3-dihydro-2H-indol-2-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529834] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H10N2O
|
||||
Canonical SMILES |
C1C2=C(C=CC(=C2)C3=CN=CC=C3)NC1=O
|
||||
InChI |
1S/C13H10N2O/c16-13-7-11-6-9(3-4-12(11)15-13)10-2-1-5-14-8-10/h1-6,8H,7H2,(H,15,16)
|
||||
InChIKey |
LRXSVYIRRDZVNQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [529834] | |
Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [529834] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen MetabolismPW000141:Steroidogenesis | ||||
WikiPathways | Metapathway biotransformation | ||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Ovarian Infertility Genes | |||||
Metabolism of steroid hormones and vitamin D | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
Corticotropin-releasing hormone | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.